MedNation Past Earnings Performance
Past criteria checks 2/6
MedNation has been growing earnings at an average annual rate of 24.4%, while the Healthcare industry saw earnings growing at 10.6% annually. Revenues have been declining at an average rate of 1.4% per year. MedNation's return on equity is 25%, and it has net margins of 6.5%.
Key information
24.4%
Earnings growth rate
24.4%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | -1.4% |
| Return on equity | 25.0% |
| Net Margin | 6.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Investors Will Want MedNation's (FRA:EIF) Growth In ROCE To Persist
Nov 19
MedNation's (FRA:EIF) Earnings Are Weaker Than They Seem
Oct 07Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost
Oct 03Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost
Oct 03The Return Trends At MedNation (FRA:EIF) Look Promising
Mar 06Investors Still Aren't Entirely Convinced By MedNation AG's (FRA:EIF) Revenues Despite 31% Price Jump
Jan 03These 4 Measures Indicate That MedNation (FRA:EIF) Is Using Debt Extensively
Dec 23MedNation (FRA:EIF) Is Looking To Continue Growing Its Returns On Capital
Oct 10MedNation AG's (FRA:EIF) 32% Dip In Price Shows Sentiment Is Matching Earnings
Jul 29Returns On Capital Are Showing Encouraging Signs At MedNation (FRA:EIF)
Jun 29Returns Are Gaining Momentum At Eifelhöhen-Klinik (FRA:EIF)
Dec 03These 4 Measures Indicate That Eifelhöhen-Klinik (FRA:EIF) Is Using Debt Extensively
Oct 09Is Eifelhöhen-Klinik (FRA:EIF) Using Debt Sensibly?
Jun 03Is Eifelhöhen-Klinik (FRA:EIF) Using Debt In A Risky Way?
Oct 16Is Eifelhöhen-Klinik (FRA:EIF) Using Too Much Debt?
Jun 07Will Eifelhöhen-Klinik's (FRA:EIF) Growth In ROCE Persist?
Feb 22Revenue & Expenses Breakdown
How MedNation makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 47 | 3 | 0 | 0 |
| 31 Mar 24 | 46 | 3 | 0 | 0 |
| 31 Dec 23 | 45 | 2 | 0 | 0 |
| 30 Sep 23 | 43 | 0 | 0 | 0 |
| 30 Jun 23 | 41 | -2 | 1 | 0 |
| 31 Mar 23 | 40 | -2 | 1 | 0 |
| 31 Dec 22 | 39 | -2 | 1 | 0 |
| 30 Sep 22 | 39 | -3 | 0 | 0 |
| 30 Jun 22 | 39 | -3 | 0 | 0 |
| 31 Mar 22 | 38 | -4 | 0 | 0 |
| 31 Dec 21 | 37 | -4 | 0 | 0 |
| 30 Sep 21 | 36 | -3 | 0 | 0 |
| 30 Jun 21 | 35 | -2 | 0 | 0 |
| 31 Mar 21 | 36 | -2 | 0 | 0 |
| 31 Dec 20 | 36 | -1 | 0 | 0 |
| 30 Sep 20 | 39 | -2 | 0 | 0 |
| 30 Jun 20 | 42 | -2 | 0 | 0 |
| 31 Mar 20 | 46 | -1 | 0 | 0 |
| 31 Dec 19 | 50 | -1 | 0 | 0 |
| 30 Sep 19 | 50 | -1 | 3 | 0 |
| 30 Jun 19 | 51 | -1 | 5 | 0 |
| 31 Mar 19 | 51 | -1 | 5 | 0 |
| 31 Dec 18 | 51 | -1 | 5 | 0 |
| 30 Sep 18 | 50 | -1 | 5 | 0 |
| 30 Jun 18 | 49 | 0 | 5 | 0 |
| 31 Mar 18 | 49 | 0 | 5 | 0 |
| 31 Dec 17 | 48 | 0 | 5 | 0 |
| 30 Sep 17 | 48 | 0 | 5 | 0 |
| 30 Jun 17 | 48 | -1 | 4 | 0 |
| 31 Mar 17 | 49 | 2 | 4 | 0 |
| 31 Dec 16 | 49 | 5 | 4 | 0 |
| 30 Sep 16 | 49 | 5 | 4 | 0 |
| 30 Jun 16 | 49 | 5 | 3 | 0 |
| 31 Mar 16 | 48 | 2 | 3 | 0 |
| 31 Dec 15 | 47 | -1 | 3 | 0 |
| 30 Sep 15 | 46 | -1 | 3 | 0 |
| 30 Jun 15 | 44 | -1 | 3 | 0 |
| 31 Mar 15 | 44 | -1 | 3 | 0 |
| 31 Dec 14 | 43 | 0 | 3 | 0 |
| 30 Sep 14 | 42 | 0 | 3 | 0 |
| 30 Jun 14 | 42 | 1 | 3 | 0 |
| 31 Mar 14 | 41 | 0 | 3 | 0 |
| 31 Dec 13 | 40 | 0 | 3 | 0 |
Quality Earnings: EIF has a large one-off gain of €2.9M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: EIF became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EIF has become profitable over the past 5 years, growing earnings by 24.4% per year.
Accelerating Growth: EIF has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: EIF has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: Whilst EIF's Return on Equity (24.97%) is high, this metric is skewed due to their high level of debt.